Neurodegenerative Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
PMN | F | ProMIS Neurosciences Inc. | -0.72 | |
TNFA | F | TNF Pharmaceuticals, Inc. | 0.81 | |
NRSNW | D | NeuroSense Therapeutics Ltd. - warrant | 0.00 | |
AMLX | C | Amylyx Pharmaceuticals, Inc. | -2.10 | |
ACTU | C | Actuate Therapeutics, Inc. | 3.29 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Neurodegenerative Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SMLF | B | iShares FactorSelect MSCI USA Small-Cap ETF | 0.09 | |
IWC | B | iShares Microcap ETF | 0.07 | |
IBB | D | iShares Nasdaq Biotechnology Index Fund | 0.03 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Nov 18 | AMLX | Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise |
Nov 14 | PMN | ProMIS Neurosciences GAAP EPS of $0.31 beats by $0.38 |
- Neurodegenerative Disease
A neurodegenerative disease is caused by the progressive loss of structure or function of neurons, in the process known as neurodegeneration. Such neuronal damage may ultimately involve cell death. Neurodegenerative diseases include amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple system atrophy, and prion diseases. Neurodegeneration can be found in the brain at many different levels of neuronal circuitry, ranging from molecular to systemic. Because there is no known way to reverse the progressive degeneration of neurons, these diseases are considered to be incurable; however research has shown that the two major contributing factors to neurodegeneration are oxidative stress and inflammation. Biomedical research has revealed many similarities between these diseases at the subcellular level, including atypical protein assemblies (like proteinopathy) and induced cell death. These similarities suggest that therapeutic advances against one neurodegenerative disease might ameliorate other diseases as well.
It is estimated that 50 million people worldwide have neurodegenerative diseases, and that by 2050 this figure will increase to 115 million people.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles